Doubling Down on mTOR Inhibition: Harnessing ZEBRA for Insights

Eur Urol. 2016 Mar;69(3):457-9. doi: 10.1016/j.eururo.2015.09.047. Epub 2015 Oct 20.

Authors

Jason Yongsheng Chan¹, Yukti Choudhury², Min-Han Tan³

Affiliations

¹ Department of Medical Oncology, National Cancer Centre Singapore, Singapore.
² Institute of Bioengineering and Nanotechnology, Singapore.
³ Department of Medical Oncology, National Cancer Centre Singapore, Singapore; Institute of Bioengineering and Nanotechnology, Singapore. Electronic address: [email protected].

PMID: 26463319
DOI: 10.1016/j.eururo.2015.09.047

No abstract available

Publication types

Editorial
Comment

MeSH terms

Animals
Cell Line, Tumor
Equidae*
Humans
Protein Kinase Inhibitors*
Signal Transduction
Sirolimus
TOR Serine-Threonine Kinases / metabolism

Substances

Protein Kinase Inhibitors
TOR Serine-Threonine Kinases
Sirolimus